Sean Lavin
Stock Analyst at BTIG
(3.10)
# 1,279
Out of 4,761 analysts
46
Total ratings
81.82%
Success rate
38.68%
Average return
Main Sectors:
Stocks Rated by Sean Lavin
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TCMD Tactile Systems Technology | Downgrades: Neutral | n/a | $15.05 | - | 4 | Nov 5, 2024 | |
| HOLX Hologic | Downgrades: Neutral | n/a | $64.49 | - | 5 | Jul 18, 2022 | |
| PODD Insulet | Upgrades: Buy | $320 | $282.80 | +13.15% | 5 | Feb 3, 2022 | |
| MDT Medtronic | Downgrades: Neutral | n/a | $89.94 | - | 1 | Jan 10, 2022 | |
| ATRC AtriCure | Maintains: Buy | $42 → $48 | $38.39 | +25.03% | 3 | Feb 19, 2020 | |
| MASI Masimo | Downgrades: Neutral | n/a | $169.96 | - | 4 | Apr 16, 2019 | |
| HSDT Helius Medical Technologies | Downgrades: Neutral | n/a | $0.54 | - | 4 | Apr 16, 2019 | |
| IRTC iRhythm Technologies | Upgrades: Buy | $80 | $119.44 | -33.02% | 3 | Apr 3, 2019 | |
| NEO NeoGenomics | Upgrades: Outperform | n/a | $11.10 | - | 4 | Apr 16, 2018 | |
| EXAS Exact Sciences | Upgrades: Buy | n/a | $49.26 | - | 3 | Apr 3, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $134.92 | - | 1 | Jan 22, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.19 | - | 1 | Dec 13, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $104.49 | - | 1 | Nov 30, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $88.78 | - | 3 | May 3, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $73.30 | - | 4 | Feb 2, 2017 |
Tactile Systems Technology
Nov 5, 2024
Downgrades: Neutral
Price Target: n/a
Current: $15.05
Upside: -
Hologic
Jul 18, 2022
Downgrades: Neutral
Price Target: n/a
Current: $64.49
Upside: -
Insulet
Feb 3, 2022
Upgrades: Buy
Price Target: $320
Current: $282.80
Upside: +13.15%
Medtronic
Jan 10, 2022
Downgrades: Neutral
Price Target: n/a
Current: $89.94
Upside: -
AtriCure
Feb 19, 2020
Maintains: Buy
Price Target: $42 → $48
Current: $38.39
Upside: +25.03%
Masimo
Apr 16, 2019
Downgrades: Neutral
Price Target: n/a
Current: $169.96
Upside: -
Helius Medical Technologies
Apr 16, 2019
Downgrades: Neutral
Price Target: n/a
Current: $0.54
Upside: -
iRhythm Technologies
Apr 3, 2019
Upgrades: Buy
Price Target: $80
Current: $119.44
Upside: -33.02%
NeoGenomics
Apr 16, 2018
Upgrades: Outperform
Price Target: n/a
Current: $11.10
Upside: -
Exact Sciences
Apr 3, 2018
Upgrades: Buy
Price Target: n/a
Current: $49.26
Upside: -
Jan 22, 2018
Downgrades: Neutral
Price Target: n/a
Current: $134.92
Upside: -
Dec 13, 2017
Downgrades: Neutral
Price Target: n/a
Current: $1.19
Upside: -
Nov 30, 2017
Upgrades: Buy
Price Target: n/a
Current: $104.49
Upside: -
May 3, 2017
Downgrades: Neutral
Price Target: n/a
Current: $88.78
Upside: -
Feb 2, 2017
Downgrades: Neutral
Price Target: n/a
Current: $73.30
Upside: -